Chief Human Resources Officer Ulrich Alison covered exercise/tax liability with 1,334 shares and was granted 7,726 shares, increasing direct ownership by 20% to 38,089 units (SEC Form 4)

$MIR
Industrial Machinery/Components
Industrials
Get the next $MIR alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ulrich Alison

(Last) (First) (Middle)
1218 MENLO DR NW

(Street)
ATLANTA GA 30318

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Mirion Technologies, Inc. [ MIR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Human Resources Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 03/01/2025 F 1,334(1) D $15.53 30,363 D
Class A Common Stock 03/01/2025 A 7,726(2) A $0 38,089 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units (RSUs) previously granted to the Reporting Person. Such withholding was mandated by the Issuer by a policy adopted in advance and does not represent a discretionary trade by the Reporting Person.
2. Represents restricted stock units that will vest in three equal annual installments starting on March 1, 2026, subject to the Reporting Person's continued employment through each vesting date.
Remarks:
/s/ Emmanuelle Lee, attorney-in-fact for Alison Ulrich 03/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $MIR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MIR

DatePrice TargetRatingAnalyst
12/19/2024$22.00Outperform
Robert W. Baird
9/26/2024$14.00Buy
B. Riley Securities
5/26/2023$11.00Buy
Citigroup
3/24/2022$13.00Market Outperform
CJS Securities
11/29/2021$14.00Buy
Goldman Sachs
10/25/2021$14.00Buy
Citigroup
More analyst ratings

$MIR
Press Releases

Fastest customizable press release news feed in the world

See more
  • Mirion Technologies Joins Influential Nuclear Energy Organizations to Further Bolster Nuclear Initiatives

    Mirion joins the Nuclear Energy Institute, enhances membership with the American Nuclear Society as a Trustees of Nuclear partner. Mirion (NYSE:MIR), a leading provider of advanced radiation safety solutions, today announced that it has joined the Nuclear Energy Institute (NEI) and the American Nuclear Society's (ANS) Trustees of Nuclear program. Membership in the two preeminent nuclear industry and professional organizations in the United States provides Mirion Technologies with an enhanced platform to engage with industry leaders and policymakers, as well as share industry expertise, on issues of importance to the nuclear sector. NEI is the policy organization of the nuclear energy indu

    $MIR
    Industrial Machinery/Components
    Industrials
  • Mirion to Present at the 46th Annual Raymond James Institutional Investor Conference

    Mirion (NYSE:MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the 46th Annual Raymond James Institutional Investor Conference. The presentation will begin at 9:15 a.m. ET on Wednesday, March 5, 2025. The presentation will be webcast live at Mirion's Investor Relations Page. The link will be displayed under the "Events and Presentations" section. An archive of the webcast will be available as well at the same location. About Mirion Mirion (NYSE:MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of

    $MIR
    Industrial Machinery/Components
    Industrials
  • Mirion to Present at Citi's 2025 Global Industrial Tech and Mobility Conference

    Mirion (NYSE:MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi's 2025 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 2:40 PM ET on Wednesday, February 19, 2025. The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations" section. An archive of the webcast will be available as well at the same location. About Mirion Mirion (NYSE:MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transf

    $MIR
    Industrial Machinery/Components
    Industrials

$MIR
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$MIR
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$MIR
SEC Filings

See more

$MIR
Leadership Updates

Live Leadership Updates

See more
  • Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

    SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

    $MIR
    Industrial Machinery/Components
    Industrials
  • Janus International Appoints David Vanevenhoven as Chief Accounting Officer

    Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

    $JBI
    $MIR
    Building Products
    Industrials
    Industrial Machinery/Components
  • Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

    Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

    $MIR
    Industrial Machinery/Components
    Industrials

$MIR
Financials

Live finance-specific insights

See more
  • Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance

     Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

    $MIR
    Industrial Machinery/Components
    Industrials
  • Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024

    Mirion (NYSE:MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until February 26, 2025. Participants may access the replay at 1-844-512-2921

    $MIR
    Industrial Machinery/Components
    Industrials
  • Mirion Announces Third Quarter 2024 Financial Results and Updates Full Year Guidance

    Revenues for the third quarter increased 8.2% to $206.8 million, compared to $191.2 million in the same period in 2023. Net loss was $14.0 million in the third quarter, compared to a net loss of $12.9 million in the same period last year. Adjusted EBITDA was $45.7 million, a 17.8% increase from $38.8 million in the same period last year. Loss from operations margin was 0.8% in the third quarter, compared to 5.8% in the same period in 2023. Adjusted EBITDA margin was 22.1% in the third quarter, compared to 20.3% in the same period last year. GAAP net loss per share for the third quarter was $0.07, compared to $0.06 in the third quarter of 2023. Adjusted earnings per share for the q

    $MIR
    Industrial Machinery/Components
    Industrials

$MIR
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more